28 min listen
Oxy’s Big Deal & Scott Gottlieb on Game-changing Gene Editing 12/11/23
FromSquawk Pod
ratings:
Length:
30 minutes
Released:
Dec 11, 2023
Format:
Podcast episode
Description
Occidental Petroleum will buy CrownRock for $12 billion, deepening its foothold in the Permian basin. Energy expert and author of “The New Map: Energy, Climate and the Clash of Nations” Daniel Yergin explains what the recent flurry of oil industry mergers means for geopolitics. The FDA has approved treatment for sickle cell disease, the first treatment to use the gene-editing tool CRISPR. Former FDA Commissioner Dr. Scott Gottlieb discusses a treatment’s journey from lab to patients, as well as improving the public’s access to life-saving care. Plus, Macy’s has a $5.8 billion buyout offer, and University of Pennsylvania’s President Elizabeth Magill has resigned after her controversial testimony on Capitol Hill last week. Daniel Yergin - 15:38Dr. Scott Gottlieb - 23:50 In this episode: Dan Yergin, @danielyerginScott Gottlieb, @ScottGottliebMDMichael Santoli, @michaelsantoliAndrew Ross Sorkin, @andrewrsorkinBecky Quick, @BeckyQuickKatie Kramer, @Kramer_Katie
Released:
Dec 11, 2023
Format:
Podcast episode
Titles in the series (100)
Musk vs. California; Virgin Galactic Chairman; Crypto & Covid: Virgin Galactic Chairman, Social Capital founder, Facebook alumnus, and outspoken investor Chamath Palihapitiya weighs in on Tesla and its famed founder, the Fed’s controversial moves, and roles governments and businesses should play during a pandemic. Plus, bestselling author Ben Mezrich has teamed up with The Boston Globe in his newest work, a slow-release novella available chapter by chapter throughout May. The writer behind “The Social Network,” “Bitcoin Billionaires,” and “Q,” a 2015 book about a pandemic forcing New York City into quarantine speaks to our new world of crypto-investing, streaming, and staying home. by Squawk Pod